Case Studies and Examples To illustrate these themes, consider a few real-world examples: Novo Nordisk Catalent Integration: In early 2024 Novo Holdings announced plans to acquire Catalent (a major CDMO) for $16.5B ( [11] )
With patent expiries lined up in India, Canada, and Brazil, the next 1218 months could be critical for companies preparing for generic entry
Types of GLP-1 medications GLP-1 therapies are available in several different forms: Once-weekly injections Daily oral or injectable options Combination therapy with insulins Xultophy (insulin degludec + liraglutide) IcoSema (weekly insulin Icodec + Semaglutide) Soliqua (insulin glargine and lixisenatide) How the main GLP-1 drugs compare While all GLP-1 medications work through similar mechanisms, they differ in strength, dosing frequency, weight loss effects, and side-effect profiles
Excess weight is known to reduce fertility
124 Moreover, many peptide drugs are not known to be substrates or inhibitors of transporters at present, indicating that transporter-mediated biliary or renal excretion may not be a major pathway for their elimination
Statin use was significantly associated with a reduced risk of HCC recurrence after PSM (p=0.01